OpenText Collaborates with Bayer to Simplify Digital Operations

OpenText™ (NASDAQ: OTEX), (TSX: OTEX), today announced that Bayer has selected OpenText™ Business Network Cloud Enterprise as a strategic solution for select B2B integration activities within the divisions Consumer Health & Pharmaceuticals, to increase agility and improve operational efficiencies. The collaboration was initiated with a proof-of-concept to be followed by roll-out activities.

OpenText logo (PRNewsfoto/Open Text Corporation) (PRNewsfoto/Open Text Corporation)

With a more than 150-year history, Bayer is one of the largest healthcare and agricultural companies in the world. By deploying Business Network Cloud Enterprise, Bayer will optimize and simplify integration with partners, enabling the organization to focus on their core business.

"We expect that our collaboration with OpenText, from the onboarding of customers through its roll out, is poised to have a significant impact on our global processes," said Björn- Christian Volckmann – Global Process Owner Order-2-Cash, Commercial Operations (Consumer Health & Pharmaceuticals). "As a global B2B EDI provider and trusted partner, OpenText will provide curated support and enable us to continue prioritizing leading edge solutions that will make a difference in communities around the world today, and well into the future."

Through industry leading Business Network Cloud Enterprise, OpenText supports the day-to-day operations relating to an organization's B2B integrations. By managing systems, integration, partner onboarding, transaction monitoring and more, OpenText enables companies to focus on their core competencies while benefitting from access to real-time business performance insights, simplified interaction with trading partners and a digital backbone that connects people, systems and things.

"With billions of B2B transactions being exchanged globally between organizations every year, successful and effective integration can be extremely costly and complex, often requiring continuous investment, specialized technology and expertise, to manage," said Muhi Majzoub, Chief Product Officer at OpenText. "By leveraging OpenText™ Business Network Cloud Enterprise, Bayer will be able to focus on their core business priorities with a simplified and harmonized system landscape that is backed and supported by one of the largest B2B Networks in the world."

To learn more about OpenText™ Business Network Cloud Enterprise read here .

About OpenText  
OpenText, The Information Company™, enables organizations to gain insight through market leading information management solutions, powered by OpenText Cloud Editions. For more information about OpenText (NASDAQ: OTEX, TSX: OTEX) visit opentext.com .

Connect with us:  
OpenText CEO Mark Barrenechea's blog
  Twitter | LinkedIn

Certain statements in this press release may contain words considered forward-looking statements or information under applicable securities laws. These statements are based on OpenText's current expectations, estimates, forecasts and projections about the operating environment, economies and markets in which the company operates. These statements are subject to important assumptions, risks and uncertainties that are difficult to predict, and the actual outcome may be materially different. OpenText's assumptions, although considered reasonable by the company at the date of this press release, may prove to be inaccurate and consequently its actual results could differ materially from the expectations set out herein. For additional information with respect to risks and other factors which could occur, see OpenText's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other securities filings with the SEC and other securities regulators. Unless otherwise required by applicable securities laws, OpenText disclaims any intention or obligations to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Copyright © 2023 OpenText. All Rights Reserved. Trademarks owned by OpenText. One or more patents may cover this product(s). For more information, please visit https://www.opentext.com/patents .

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/opentext-collaborates-with-bayer-to-simplify-digital-operations-301759462.html

SOURCE Open Text Corporation

News Provided by PR Newswire via QuoteMedia

OTEX:CA
The Conversation (0)
Rocketboots Limited

Appendix 4D & Half Year Report (1H25)

Artificial Intelligence software companyRocketBoots Limited (ASX:ROC) (RocketBoots or the Company) has announced Appendix 4D & Half Year Report (1H25).


Keep reading...Show less
Nanoveu

Binding Share Sale Agreement Executed with EMASS

Nanoveu positioned to accelerate growth in AI-driven edge semiconductor solutions

Nanoveu Limited ("Nanoveu" or the "Company") (ASX: NVU), following on from its announcements on 15 October 2024 and 22 November 2024, is pleased to announce the completion of its binding Share Sale Agreement regarding its 100% acquisition of Embedded A.I. Systems Pte. Ltd. (“EMASS”), a leading System-on-Chip (SoC) semiconductor design company, following shareholder approval and completion of due diligence4. This transaction marks a key strategic moment for Nanoveu and adds cutting edge semiconductor technology to its suite of commercial offerings.

Keep reading...Show less
BlinkLab

North Shore Pediatric Therapy in Chicago Joins BlinkLab’s US Registrational Study

BlinkLab Limited (ASX:BB1) (“BlinkLab”, or the “Company”), an innovative digital healthcare company developing AI-powered smartphone technology to transform the autism and ADHD diagnostic markets, is pleased to announce that North Shore Pediatric Therapy (“NSPT”) is joining our US clinical study. NSPT is the second US-based site to on-board for the 100-patient initial phase of the registrational study. Enrolment from the NSPT-site is expected to commence in the coming weeks.

Keep reading...Show less
Bar chart.

Tech 5: AMD, Alphabet, Amazon and More Report Results as Big Tech Earnings Roll Out

Trade tensions dominated the macroeconomic landscape this week, impacting the tech sector.

US President Donald Trump's confirmation of tariffs against Canada and Mexico resulted in significant market losses on Monday (February 3) before negotiations led to temporary delays in their implementation.

Uncertainties are ongoing, but investors remained resilient, seizing opportunities in the face of volatility as Big Tech earnings reports drove fluctuations in the Nasdaq Composite (INDEXNASDAQ:.IXIC) and S&P 500 (INDEXSP:.INX).

Keep reading...Show less
ChatGPT logo overlayed on human profile.

How to Invest in OpenAI's ChatGPT

OpenAI’s ChatGPT is one of the latest technological breakthroughs in the artificial intelligence space. But what is ChatGPT, and can you invest in OpenAI?

This emerging technology is representative of a niche subsector of the AI industry known as generative AI — systems that can generate text, images or sounds in response to prompts given by users.

Precedence Research expects the global AI market to grow at a compound annual growth rate (CAGR) of 19.1 percent to reach US$3.68 trillion by 2034. Just how much of an impact OpenAI’s ChatGPT will have on this space is hard to predict, but Fortune Business Insights estimates that the total market revenue of generative AI will see a CAGR of 39.6 percent through 2032, increasing from US$67.18 billion last year to US$967.65 billion in 2032.

Keep reading...Show less

Latest Press Releases

Related News

×